Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Triple-Negative Breast Cancer
Jonathan D. Marotti, Francine B. de Abreu, Wendy A. Wells, et al.
American Journal Of Pathology (2017) Vol. 187, Iss. 10, pp. 2133-2138
Open Access | Times Cited: 69

Showing 26-50 of 69 citing articles:

Induction of Apoptosis in MDA-MB-231 Cells Treated with the Methanol Extract of Lichen Physconia hokkaidensis
Ji-In Noh, Seul‐Ki Mun, Eui Hyeon Lim, et al.
Journal of Fungi (2021) Vol. 7, Iss. 3, pp. 188-188
Open Access | Times Cited: 18
Incidence and Prognostic Significance of Androgen Receptors (AR) in Indian Triple-Negative Breast Cancer (TNBC)
Anjali Mishra, Shravan Kumar Mishra, Vikram Sharanappa, et al.
Indian Journal of Surgical Oncology (2024) Vol. 15, Iss. 2, pp. 250-257
Closed Access | Times Cited: 2
Genetic alterations and their association with clinicopathologic characteristics in advanced breast carcinomas: focusing on clinically actionable genetic alterations
C. Eric Freitag, Ping Mei, Lai Wei, et al.
Human Pathology (2020) Vol. 102, pp. 94-103
Closed Access | Times Cited: 19
Cancer-Testis Antigens in Triple-Negative Breast Cancer: Role and Potential Utility in Clinical Practice
Runyi Adeline Lam, Tracy Zhijun Tien, Craig Ryan Joseph, et al.
Cancers (2021) Vol. 13, Iss. 15, pp. 3875-3875
Open Access | Times Cited: 17
Targeted Sequencing of Plasma-Derived vs. Urinary cfDNA from Patients with Triple-Negative Breast Cancer
Henrike Herzog, Şenol Doğan, Bahriye Aktas, et al.
Cancers (2022) Vol. 14, Iss. 17, pp. 4101-4101
Open Access | Times Cited: 11
Molecular Biology Mechanisms and Emerging Therapeutics of Triple-Negative Breast Cancer
Zhiying Zhang, Rui Zhang, Donghai Li
Biologics (2023) Vol. Volume 17, pp. 113-128
Open Access | Times Cited: 6
Clinical target sequencing for precision medicine of breast cancer
Junko Tsuchida, Jami Rothman, Kerry-Ann McDonald, et al.
International Journal of Clinical Oncology (2019) Vol. 24, Iss. 2, pp. 131-140
Closed Access | Times Cited: 19
Fatty acid synthetase expression in triple-negative breast cancer
Jin Hee Park, Hye Seung Han, So Dug Lim, et al.
Journal of Pathology and Translational Medicine (2022) Vol. 56, Iss. 2, pp. 73-80
Open Access | Times Cited: 9
Long Non Coding RNA in Triple Negative Breast Cancer: A Promising Biomarker in Tumorigenesis
Srividhya Nandagopal, Sanjeev Misra, Shrimanjunath Sankanagoudar, et al.
Asian Pacific Journal of Cancer Prevention (2023) Vol. 24, Iss. 1, pp. 49-59
Open Access | Times Cited: 4
In vitro and in vivo activity of a novel oxamide-hydrazone hybrid derivative against triple-negative breast cancer
Raheleh Tahmasvand, Soudeh Dehghani, Zahra Kooshafar, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2024) Vol. 397, Iss. 7, pp. 5119-5129
Closed Access | Times Cited: 1
SOCS1 is associated with clinical progression and acts as an oncogenic role in triple‐negative breast cancer
Qian Qian, Yuetao Lv, Peng Li
IUBMB Life (2018) Vol. 70, Iss. 4, pp. 320-327
Open Access | Times Cited: 12
Metronomic chemotherapy (mCHT) in metastatic triple-negative breast cancer (TNBC) patients: results of the VICTOR-6 study
Marina Elena Cazzaniga, I. Vallini, Emilia Montagna, et al.
Breast Cancer Research and Treatment (2021) Vol. 190, Iss. 3, pp. 415-424
Open Access | Times Cited: 10
Next-Generation Breast Cancer Omics
William B. Coleman
American Journal Of Pathology (2017) Vol. 187, Iss. 10, pp. 2130-2132
Open Access | Times Cited: 10
Bioinformatics Analysis of Metabolomics Data Unveils Association of Metabolic Signatures with Methylation in Breast Cancer
Fadhl Alakwaa, Masha G. Savelieff
Journal of Proteome Research (2019) Vol. 19, Iss. 7, pp. 2879-2889
Closed Access | Times Cited: 10
Glycans unique to the relapse-prone subset within triple-negative breast cancer as revealed by lectin array-based analysis of surgical specimens
Madoka Sakata-Matsuzawa, Kaori Denda‐Nagai, Haruhiko Fujihira, et al.
PLoS ONE (2021) Vol. 16, Iss. 5, pp. e0250747-e0250747
Open Access | Times Cited: 9
Arrabidaea chica chloroform extract modulates estrogen and androgen receptors on luminal breast cancer cells
Douglas Cardoso Brandão, Paula Marynella Alves Pereira Lima, Isabella Castro Martins, et al.
BMC Complementary Medicine and Therapies (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 6
Long Non-coding RNA LINC01224 Promotes the Malignant Behaviors of Triple Negative Breast Cancer Cells via Regulating the miR-193a-5p/NUP210 Axis
Kai Sang, Tongbo Yi, Pan Chi, et al.
Molecular Biotechnology (2022)
Closed Access | Times Cited: 6
A triple combination gemcitabine + romidepsin + cisplatin to effectively control triple-negative breast cancer tumor development, recurrence, and metastasis
Pawat Pattarawat, Jessica T. Hunt, Jacob Poloway, et al.
Cancer Chemotherapy and Pharmacology (2021) Vol. 88, Iss. 3, pp. 415-425
Open Access | Times Cited: 8
Sequence analysis in Familial Mediterranean Fever patients with no confirmatory genotype
Vasiliki Sgouropoulou, Evangelia Farmaki, Theophanis Papadopoulos, et al.
Rheumatology International (2021) Vol. 42, Iss. 1, pp. 15-22
Closed Access | Times Cited: 8
Paclitaxel-loaded hybrid exosome for targeted chemotherapy of triple-negative breast cancer
Jihua Liu, Yu-Cheng Tang, Yongjiang Li, et al.
Research Square (Research Square) (2022)
Open Access | Times Cited: 5
Application of a Biphasic Mathematical Model of Cancer Cell Drug Response for Formulating Potent and Synergistic Targeted Drug Combinations to Triple Negative Breast Cancer Cells
Jinyan Shen, Li Li, Niall G. Howlett, et al.
Cancers (2020) Vol. 12, Iss. 5, pp. 1087-1087
Open Access | Times Cited: 7
Long Non-coding RNA BTG3-7:1 and JUND Co-regulate C21ORF91 to Promote Triple-Negative Breast Cancer Progress
Dan Zheng, Xiujing He, Ting Luo, et al.
Frontiers in Molecular Biosciences (2021) Vol. 7
Open Access | Times Cited: 6
Targeting dimethylarginine dimethylaminohydrolase 1 to suppress vasculogenic mimicry in breast cancer: Current evidence and future directions
Arduino A. Mangoni, Julie-Ann Hulin, Lashika Weerakoon, et al.
Elsevier eBooks (2023), pp. 117-133
Closed Access | Times Cited: 2
Methylated p16 gene is associated with negative expression of estrogen receptor, progesterone receptor and human epidermal growth factor receptor 2 in breast cancer
Shunli Zhang, Yaqi Wang, Jinghua Zhang, et al.
European Journal of Gynaecological Oncology (2021) Vol. 42, Iss. 3, pp. 530-530
Open Access | Times Cited: 5
Detection of a novel panel of 24 genes with high frequencies of mutation in gastric cancer based on next-generation sequencing
Huihui Zeng, Ze Yang, Yebei Qiu, et al.
World Journal of Clinical Cases (2022) Vol. 10, Iss. 15, pp. 4761-4775
Open Access | Times Cited: 3

Scroll to top